Iovance Biotherapeutics Inc (IOVA)
10.24
-0.19
(-1.82%)
USD |
NASDAQ |
May 17, 16:00
10.15
-0.09
(-0.88%)
Pre-Market: 20:00
Iovance Biotherapeutics Total Liabilities (Quarterly): 189.81M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 189.81M |
| December 31, 2023 | 195.74M |
| September 30, 2023 | 178.31M |
| June 30, 2023 | 178.72M |
| March 31, 2023 | 157.89M |
| December 31, 2022 | 164.34M |
| September 30, 2022 | 152.19M |
| June 30, 2022 | 138.19M |
| March 31, 2022 | 149.26M |
| December 31, 2021 | 155.67M |
| September 30, 2021 | 130.50M |
| June 30, 2021 | 108.38M |
| March 31, 2021 | 103.14M |
| December 31, 2020 | 111.96M |
| September 30, 2020 | 70.45M |
| June 30, 2020 | 59.26M |
| March 31, 2020 | 44.98M |
| December 31, 2019 | 45.68M |
| September 30, 2019 | 40.68M |
| June 30, 2019 | 38.50M |
| March 31, 2019 | 26.57M |
| December 31, 2018 | 14.63M |
| September 30, 2018 | 16.67M |
| June 30, 2018 | 14.18M |
| March 31, 2018 | 14.69M |
| Date | Value |
|---|---|
| December 31, 2017 | 9.892M |
| September 30, 2017 | 8.529M |
| June 30, 2017 | 8.86M |
| March 31, 2017 | 5.503M |
| December 31, 2016 | 4.968M |
| September 30, 2016 | 3.194M |
| June 30, 2016 | 4.606M |
| March 31, 2016 | 1.83M |
| December 31, 2015 | 1.63M |
| September 30, 2015 | 2.855M |
| June 30, 2015 | 1.866M |
| March 31, 2015 | 1.911M |
| December 31, 2014 | 1.662M |
| September 30, 2014 | 1.259M |
| June 30, 2014 | 1.156M |
| March 31, 2014 | 1.276M |
| December 31, 2013 | 2.270M |
| September 30, 2013 | 3.509M |
| June 30, 2013 | 3.369M |
| March 31, 2013 | 12.31M |
| December 31, 2012 | 11.35M |
| September 30, 2012 | 16.61M |
| June 30, 2012 | 16.68M |
| March 31, 2012 | 17.34M |
| December 31, 2011 | 13.35M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
38.50M
Minimum
Jun 2019
195.74M
Maximum
Dec 2023
120.68M
Average
134.34M
Median
Total Liabilities (Quarterly) Benchmarks
| Viatris Inc | 27.33B |
| Perspective Therapeutics Inc | 48.40M |
| Electromed Inc | 6.357M |
| Xtant Medical Holdings Inc | 46.25M |
| Asensus Surgical Inc | 27.79M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 869.83M |
| Shareholders Equity (Quarterly) | 680.02M |
| Debt to Equity Ratio | 0.0015 |
| Current Ratio | 4.633 |